Tobacco Cessation in Postmenopausal Women (Part I) - 1
The Effects of ERT on Appetitive Behavior and Withdrawal in Short-term Smoking Cessation Compared to Smoking ad Lib in Postmenopausal Female Smokers.
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to evaluate the effects of ERT on appetitive behavior and withdrawal in short-term smoking cessation compared to smoking ad lib in postmenopausal female smokers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 1997
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 1997
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2003
CompletedFirst Submitted
Initial submission to the registry
May 21, 2003
CompletedFirst Posted
Study publicly available on registry
May 22, 2003
CompletedDecember 2, 2015
December 1, 2015
6 years
May 21, 2003
December 1, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Smoking Cessation Outcomes
3 months
Interventions
Eligibility Criteria
You may qualify if:
- Female smokers ages 40-79, smoking at least 15 cigarettes per day for at least one year, have natural menopause, have a transvaginal ultrasound to confirm loss of follicular activitiy, have a normal baseline mammogram, a normal chemistry at baseline, willing to take hormone replacement therapy for the duration of the study, normal thyroid function, and have a normal TSH.
You may not qualify if:
- Women who have had formal dieting with or without pharmacological methods within the last three months; a weight change greater than or equal to 10 pounds within the last three months, BMI greater than or equal to 40, severe menopausal symptoms, active medical problems, alcohol or drug abuse, other forms of nicotine use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharon Allen, Ph.D., M.D.
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2003
First Posted
May 22, 2003
Study Start
March 1, 1997
Primary Completion
March 1, 2003
Study Completion
March 1, 2003
Last Updated
December 2, 2015
Record last verified: 2015-12